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Goueffic Y., Jean-Baptiste E., Cochennec F., Favre J.-P., Association Uni-
versitaire de Recherche en Chirurgie Vasculaire (AURC). Eur J Vasc Endo-
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Purpose: This study aims to evaluate the medium-term outcomes
following aortic aneurysm repair using fenestrated endografts performed in
16 French academic centres.
Materials and methods: A retrospective analysis of prospectively
collected data was carried out. This study included all patients treated with
fenestrated endografts in France between May 2004 and January 2009.
Patients were judged to be at high risk for open surgical repair. Fenestrated
endografts were designed using computed tomography (CT) reconstruc-
tions performed on three-dimensional (3D) workstations. All patients were
evaluated with CT, duplex ultrasound and plain film radiograph at dis-
charge, 6, 12, 18 and 24 months, and annually thereafter.
Results:A total of 134 patients (129males) were treated over the study
period. Median age and aneurysm size were 73 years (range 48–91 years)
and 56 mm (range 45–91 mm), respectively. A total of 403 visceral vessels
were perfused through a fabric fenestration, including 265 renal arteries.
One early conversion to open surgery was required. Completion angiogra-
phy and discharge CT scan showed that 398/403 (99%) and 389/394
(99%) respective target vessels were patent. The 30-daymortality rate was 2%
(3/134). Pre-discharge imaging identified 16 (12%) endoleaks: three type I,
12 type II and one type III. After the procedure, transient or permanent
dialysis was required in four (3%) and two (1%) patients, respectively. The
median duration of follow-up was 15 months (range 2–53 months). No
aneurysms ruptured or required open conversion during the follow-up
period. Twelve of 131 patients (9%) died during follow-up (actuarial survival
at 12 and 24 months: 93% and 86%, respectively). Median time from
procedure to death was 15 months. None of these deaths were aneurysm
related. Aneurysm sac size decreased by more than 5 mm in 52%, 65.6% and
75% of patients at 1, 2 and 3 years, respectively. Three (4%) patients had sac
enlargement within the first year, associated with a persistent endoleak.
During follow-up, four renal artery occlusions were detected. A total of 12
procedure-related re-interventions were performed in 12 patients during
follow-up, including six to correct endoleaks, and five to correct threatened
visceral vessels.
Conclusions: The use of endovascular prostheses with graft material
incorporating the visceral arteries is safe and effective in preventing rupture
in the medium term. A predictable high mortality rate was depicted during
follow-up in this high-risk cohort. Meticulous follow-up to assess sac behav-
iour and visceral ostia is critical to ensure optimal results.
Secondary Interventions Following Endovascular Aneurysm Repair
(EVAR) and the Enduring Value of Graft Surveillance
Nordon I.M., Karthikesalingam A., Hinchliffe R.J., Holt P.J., Loftus I.M.,
Thompson M.M. Eur J Vasc Endovasc Surg 2010;39:in press.
Objective: Lifelong imaging surveillance is currently recommended for
all patients following endovascular aortic aneurysm repair (EVR). The
modality, timing and overall necessity of surveillance has recently been
brought into question. This review reports contemporary secondary inter-
vention rates and explores surveillance imaging pick-up rates and reports
the evidence supporting modified EVR surveillance programs.
Design: Systematic review of literature (2002–2009) andmeta-analysis
of Kaplan–Meier re-intervention-free survival estimates.
Results: 32 Papers were included in final analysis. 17,987 EVR cases
were reported. Crude annual secondary intervention rates from the US
population registries were 3.7%/year (range 1.7–4.3%). Combined re-
intervention-free survival estimates, from 14 series (10,365 cases), demon-
strated a linear progression with 89.9%, 86.9% and 81.5% of grafts without
secondary procedures at 2, 3 and 5 years respectively.
3 Reports (1249 cases) differentiated between interventions directed
by surveillance or outside surveillance protocols. Surveillance imaging alone
initiated the secondary interventions in 1.4–9% of cases;90% of EVR cases
received no benefits from surveillance scans.
Discussion: Some format of surveillance following EVR probably
remains necessary despite a reduction in secondary interventions with mod-
ern stent-grafts. Surveillance should be targeted at those stent-grafts and
patients at high risk of complications. Further work is justified to identify this
group.Different Effects of Commonly Prescribed Statins on Abdominal Aor-
tic Aneurysm Wall Biology
Hurks R., Hoefer I.E., Vink A., Pasterkamp G., Schoneveld A., Kerver M.,
de Vries J.-P.PM., Tangelder M.J., Moll F.L. Eur J Vasc Endovasc Surg
2010;39:in press.
Background: Pharmaceutical stabilisation of the abdominal aortic
aneurysm (AAA) wall can delay surgery and improve outcome. Observa-
tional studies indicate statins can be used to reduce AAA growth but
mechanistic data are scarce. In this study, our aim was to determine the
pleiotropic effects of different statins on AAA wall composition.
Methods: We included 216 patients undergoing open AAA repair, of
which 60 used simvastatin, 52 atorvastatin and 23 pravastatin. The AAAwall
histology and protein expression (IL 1,2,4,5,6,8,10,12, interferon-gamma
(IFN), tumour necrosis factor (TNF),, matrix metalloproteinase
(MMP)2 and 9 activities, total MMP8,9 and cathepsin A and B levels)
between statin users and non-users were compared as also among the use of
different statins.
Results: As far as histological inflammation goes, the AAA walls of
statin users did not differ from those not using them. After multivariate
adjustment for risk factors, pravastatin use was associated with tendencies of
increased MMP8 (p  0.022), active MMP9 (p  0.040) and higher ca-
thepsin B (p  0.056) levels. The AAA walls of simvastatin and atorvastatin
users showed no differences in proteases or cytokines in multivariate analy-
ses.
Conclusions: The use of statins was not associated with a decrease in
protease levels or inflammation. The trends of elevated protease levels
associated with pravastatin use suggest pleiotropic differences among the
various statins, supporting the need for further research to target pharma-
ceutical AAA treatment.
Interobserver Agreement of the TASC II Classification for Supra- and
Infrainguinal Lesions
Zimmermann A., Wendorff H., Schuster T., Auer F., Berger H., Eckstein
H.-H. Eur J Vasc Endovasc Surg 2010;39:in press.
Objectives: The Trans-Atlantic Inter-Society Document on Manage-
ment of Peripheral Arterial Disease (TASC) gives treatment recommenda-
tions depending on the classification of aorto-iliacal or femoro-popliteal
vascular pathologies. Therefore, the best treatment could only be offered if
the right TASC classification was obtained. The purpose of this study was to
assess the interobserver agreement of the evaluation of the TASC II classi-
fication for peripheral arterial occlusive disease (PAOD) in magnetic reso-
nance angiography (MRA).
Patients and methods: Three hundred arterial segments of 149 pa-
tients with a magnetic MRA for PAOD were evaluated according to the
TASC II classification. A resident and a consultant for radiology and vascular
surgery both performed independent grading. A comparative assessment of
the consensus agreement was quantified by the marginal probabilities calcu-
lated by generalised estimation equation models, as well as by using the
weighted kappa coefficient (), classified according to Altman.
Results: In relation to the consensus, the overall agreement was good
to excellent for the consultants of radiology and vascular surgery. The
consultants obtained a statistically significant higher agreement than did the
residents (Odds ratio (OR): 2.86, 95% confidence interval (CI): 2.21–3.69,
p  0.001). A significantly higher consensus agreement probability was
observed for the surgeons compared with the radiologists (OR: 1.43, 95%
CI: 1.11–1.84, p  0.006) and for the femoro-popliteal regions compared
with the aorto-iliacal regions (OR: 1.64, 95% CI: 1.12–2.14, p  0.012).
Conclusion: Although good results can be achieved in the assessment
of vascular lesions according to the TASC II document, a simplification of
this classification could increase its practicability in a daily clinical routine.
Predictive Risk Factors for Restenosis after Remote Superficial Femoral
Artery Endarterectomy
DerksenW.J.M., Gisbertz S.S., Hellings W.E., Vink A., de Kleijn D.P.V., de
Vries J.-P.P.M., Moll F.L., Pasterkamp G. Eur J Vasc Endovasc Surg
2010;39:in press.Objectives: Restenosis following remote superficial femoral artery
endarterectomy (RSFAE) remains a challenging problem. The determinants
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May 20101324 Abstractspredicting failure are lacking. This study investigated patient characteristics
with predictive value for restenosis during the first year after RSFAE.
Design: A prospective cohort study.
Materials and methods: A total of 90 patients post-RSFAE were
studied for the occurrence of restenosis “(peak systolic velocity ratio 2.5)”
in the first 12 months postoperatively. At baseline, clinical parameters were
recorded. Vessel size was measured on the basis of plaque perimeter in the
culprit lesion and lumen diameter on perioperative digital subtraction an-
giography.
Results: In 57 patients (63%), a restenotic lesion was diagnosed within
12 months following surgery. Patients with longer time interval between
start of ischaemic walking complaints and RSFAE revealed a significantly
higher incidence of restenosis (hazard ratio (HR)  1.3 (1.05–1.52) per 4
years). Small plaque perimeter and small superficial femoral artery (SFA)
diameter on angiography were significantly associated with restenosis
(HR  0.54 (0.34–0.88) per 10 mm and HR  0.46 (0.27–0.78) per
1.5 mm, respectively). In multivariate analysis, age, duration of ischaemic
walking complaints and lumen diameter were independently associated with
increased risk of restenosis after RSFAE.
Conclusions: This study provides evidence that age, vessel size and
duration of ischaemic walking complaints before RSFAE are predictive
values for restenosis after RSFAE.
Basilic Vein Transposition: What is the Optimal Technique?
Kakkos S.K., Haddad G.K., Weaver M.R., Haddad R.K., Scully M.M. Eur J
Vasc Endovasc Surg 2010;39:in press.
Objectives: To compare the outcome of the one-stage basilic vein
transposition (BVT) fistula with a modified, two-stage technique.
Design: Retrospective case-controlled study, performed in an aca-
demic centre.
Material:A total of 173 candidates for BVT fistula (87males, mean age
61 years).
Methods: In one-stage BVT, the basilic vein is mobilised through a
single incision, placed inside an anterolateral arm tunnel and anastomosed
with the brachial artery. In two-stage procedures, the fistula–arterial anasto-
mosis is created first, followed by the second stage, after fistula maturation
several weeks later, when the basilic vein is mobilised through two skip
incisions, transected near the anastomosis, placed inside an anterolateral arm
tunnel and reanastomosed. Morbidity and fistula maturation rate were the
main outcome measures.
Results: In one-stage BVT (n  76), the incidence of venous hyper-
tension, wound haematomas and all complications (17%, 13% and 43%,
respectively) was significantly higher than in two-stage procedures (n  98)
(4%, p  0.004, 3%, p  0.012 and 11%, p  0.001, respectively). Time (68
days) to fistula use was significantly decreased in one-stage BVT than in
two-stage procedures (132 days, p  0.001) but failure to mature rate was
equivalent (15% vs. 18%, p  0.49).
Conclusions: Our results indicate that the two-stage BVT fistula
through two skip-arm incisions is superior to the established one-stage
procedure in terms of less morbidity but at the cost of a second operation
and longer time to access use. Further research comparing these twoReaders can access EJVES articles at http://intl.eRandomised Clinical Trial Comparing Endovenous Laser Ablation
with Stripping of the Great Saphenous Vein: Clinical Outcome and
Recurrence After 2 Years
Rasmussen L.H., Bjoern L., Lawaetz M., Lawaetz B., Blemings A., Eklöf B.
Eur J Vasc Endovasc Surg 2010;39:in press.
Objective: This study aims to compare the outcome 2 years after
treatment of varicose veins by endovenous laser ablation (EVLA) or surgery
by assessing recurrence, venous clinical severity score (VCSS) and quality of
life.
Methods: A total of 121 patients (137 legs) were randomised to either
EVLA or saphenofemoral ligation and stripping of the great saphenous vein
(GSV). Follow-up included clinical and duplex ultrasound examinations,
VCSS and quality of life questionnaires.
Results: A total of 18 (26%) and 25 patients (37%) in the EVLA and
surgery group, respectively, developed recurrent varicose veins (not signifi-
cant (NS) between groups). The source of reflux was not significantly
different between the groups. Technical failure occurred in three EVLA and
two surgery patients, reflux in the anterior accessory GSV, the groin, thigh
and calf perforators was found in six, two, four, and three EVLA patients,
and in three, three, nine and six surgery patients. VCSS, Aberdeen Varicose
Vein Severity Score and several domains of the Medical Outcomes Study
Short Form 36 (SF36) quality of life score improved significantly in both
groups.
Conclusions:No significant differences in clinical or ultrasound recur-
rences were found between EVLA and surgery groups. Our study also shows
that similar improvements in clinical severity scores and quality of life were
gained in both treatments.
Primary Lymphoedema and Lymphatic Malformation: Are they the
Two Sides of the Same Coin?
Lee B.B., Villavicencio J.L. Eur J Vasc Endovasc Surg 2010;39:in press.
Objectives: To clear the confusion regarding the relationship between
the ‘primary lymphoedema’ and (truncular) lymphatic malformation (LM);
the latter is one of congenital vascular malformations.
Materials & Methods: A literature review was carried out on the
primary lymphoedema either existing as an independent LM lesion or as a
component of the Klippel–Trenaunay syndrome.
Results: The review was able to provide a contemporary guide/
conclusion on the definition and classification, clinical evaluation and clinical
management regarding conservative (physical) therapy, reconstructive sur-
gical therapy and ablative/excisional surgical therapy, for the primary lym-
phoedema as an LM.
Conclusions: Primary lymphoedema can be considered as ‘congenital’
since its majority represents a clinical manifestation of the truncular type of
LM arising during the later stages of lymphangiogenesis. Such embryolog-
ical staging information of the LM is critical for proper management of the
primary lymphoedema when it exists with other congenital vascular malfor-
mations (Klippel–Trenaunay syndrome).
2. Basic non-invasive to minimally invasive tests will provide an ade-
quate diagnosis and lead to the correct multidisciplinary, specifically targeted
and sequenced treatment strategy.
3. The mainstay of current management of the primary lymphoedema/
techniques is necessary. Until this issue is resolved, an individualised ap-
proach is suggested.
truncular LM is complex decongestive therapy; and the reconstructive as
well as ablative surgical therapy remain adjunctive therapies at best.lsevierhealth.com/journals/ejvs/default.cfm
